Results 151 to 160 of about 39,488 (201)

Haemophilus influenzae Type b Conjugate Vaccines

1995
In summary, all of the Hib conjugate vaccines are highly immunogenic and efficacious in children older than 12-15 months of age, and HbOC, PRP-OMPC, and PRP-T are highly immunogenic and demonstrated to be efficacious in infants as young as 2 months old.
P J, Kniskern, S, Marburg, R W, Ellis
openaire   +2 more sources

Haemophilus influenzae Type b Infections in Adults

Scandinavian Journal of Infectious Diseases, 1989
31 cases of invasive Haemophilus influenzae type b infections occurred in adults in Denmark during a period of 2 years and 5 months corresponding to an incidence of 0.3/100,000/year. Only 6 patients had no underlying condition. The incidence of H. influenzae type b infections in adults will probably rise in the future, because the increasing use of ...
openaire   +2 more sources

A decline in Haemophilus influenzae type b meningitis

The Journal of Pediatrics, 1993
During the past 50 years, there has been an unexplained fourfold increase in admissions for Haemophilus influenzae type b meningitis to the Children's Hospital of Pittsburgh, and an equally striking decline that cannot be attributed entirely to immunization.
R H, Michaels, O, Ali
openaire   +2 more sources

Ampicillin Resistance and Haemophilus influenzae Type b

Archives of Pediatrics & Adolescent Medicine, 1985
Sir .—Your commentary 1 states that "Ampicillin resistance has been demonstrated in nontype b strains although at a much lower level than that observed by type b organisms." The reference to Long et al 2 is provided to support that statement. I believe this is an incorrect statement and that the cited reference does not support it. The study of Long et
openaire   +2 more sources

Haemophilus influenzae type b unsuspected bacteremia

Pediatric Emergency Care, 1987
To further define the clinical features and natural history of unsuspected Haemophilus influenzae type b (Hib) bacteremia, we retrospectively reviewed the records of 322 Hib infections observed during a 45-month period at Children's Hospital, Boston. We identified 31 patients with unsuspected Hib bacteremia and 19 with unsuspected Hib antigenemia and ...
A B, Anderson, D M, Ambrosino, G R, Siber   +2 more
openaire   +2 more sources

Haemophilus influenzae type b: the search for a vaccine

The Pediatric Infectious Disease Journal, 1987
In adults Hib CPS protein conjugates are much more immunogenic than the polysaccharide alone; further studies have shown that they induce a booster response in children. The antibodies produced in response to the conjugates have the same biologic properties, isotype and IgG subclass composition as those elicited by Hib CPS alone or those present in ...
J B, Robbins, R, Schneerson
openaire   +2 more sources

Ceftriaxone in Haemophilus influenzae Type b Meningitis

JAMA: The Journal of the American Medical Association, 1988
To the Editor. —Jacobs et al 1 report the first apparent case, to my knowledge, of a failure of ceftriaxone to sterilize cerebrospinal fluid (CSF) after three days of therapy in a child with Haemophilus influenzae type b pneumonia with sepsis. This information stands in contrast to a large body of clinical data in which ceftriaxone has been used to ...
openaire   +2 more sources

Prevention of Haemophilus influenzae type b disease

Vaccine, 1993
Haemophilus influenzae type b (Hib) is the leading cause of meningitis in children < 5 years of age. The majority of cases of Hib occur in infants < 2 years of age. Until recently the only vaccine available against this disease contained the pure polysaccharide (PRP) of Hib (Hib-PRP vaccine).
openaire   +2 more sources

HAEMOPHILUS INFLUENZAE NON TYPE b

The Lancet, 1985
R A, Wall, D C, Mabey, P T, Corrah
openaire   +2 more sources

Haemophilus influenzae type b vaccination

The Lancet, 1997
A, Melhus, A, Hemansson
openaire   +2 more sources